Merck KGaA, Darmstadt, Germany completes acquisition of Intermolecular, Inc.


Integration Milestones

On May 6, 2019: Agreement on Acquisition

On May 6, 2019: Agreement on Acquisition

Merck KGaA, Darmstadt, Germany signs definitive agreement to acquire Intermolecular for $1.20 per share in an all cash transaction.

See press release here

On July 18, 2019: Shareholder Approval

On July 18, 2019: Shareholder Approval

Merck KGaA, Darmstadt, Germany announced that its proposed transaction with Intermolecular, Inc. (NASDAQ: IMI) was approved by the stockholders of Intermolecular at a special meeting held on July 17, 2019.

See press release here

On September 20, 2019: Closing

On September 20, 2019: Closing

Merck KGaA, Darmstadt, Germany completes acquisition of Intermolecular

  • US$ 62 million acquisition to strengthen semiconductor technology offering
  • Combined portfolio to accelerate materials innovation and shorten time-to-market 
  • Additional milestone for proposed Versum acquisition achieved

See press release here

Merck KGaA, Darmstadt, Germany

Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 52,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2018, Merck KGaA, Darmstadt, Germany, generated sales of € 14.8 billion in 66 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.

Go to Merck KGaA, Darmstadt, Germany - Performance Materials' Website

Intermolecular Inc.

Intermolecular possesses application-specific materials expertise, accelerated learning and experimentation platforms with a powerful analytics infrastructure that complement the business and technology portfolio of Merck KGaA, Darmstadt, Germany.  Intermolecular’s fabrication and testing capabilities allow for material combinations to be tested directly within the specific target application. In comparison with conventional methods, these capabilities translate to major time reductions in the development process, dramatically accelerated learning cycles and insights into novel material systems to provide customers with a unique service value.

Go to Intermolecular's Website

"We successfully complete the acquisition and welcome Intermolecular! Since three and a half centuries, we are dedicated to advancing science and technology for the benefit of human progress. I am glad that Intermolecular shares this spirit. Together we are well-positioned to drive innovations in the elctronic industry."

Kai Beckmann

Member of the Executive Board Merck KGaA, Darmstadt, Germany & CEO Performance Materials

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement